Publication | Open Access

BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer

OncologyMetronomic TherapyClinical TrialsBronchial NeoplasmFirst-line TreatmentCancer TreatmentMedicineRadiation OncologyLung CancerMolecular OncologyHealth Sciences